Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.

1. We have retrospectively analysed data collected by a local adverse drug reactions reporting scheme in an acute hospital medical setting and have determined the numbers and types of reactions that would have merited notification as yellow card reports according to the guidelines of the Committee o...

Full description

Bibliographic Details
Main Authors: Smith, C, Bennett, P, Pearce, H, Harrison, P, Reynolds, D, Aronson, J, Grahame-Smith, D
Format: Journal article
Language:English
Published: 1996
_version_ 1797065636737712128
author Smith, C
Bennett, P
Pearce, H
Harrison, P
Reynolds, D
Aronson, J
Grahame-Smith, D
author_facet Smith, C
Bennett, P
Pearce, H
Harrison, P
Reynolds, D
Aronson, J
Grahame-Smith, D
author_sort Smith, C
collection OXFORD
description 1. We have retrospectively analysed data collected by a local adverse drug reactions reporting scheme in an acute hospital medical setting and have determined the numbers and types of reactions that would have merited notification as yellow card reports according to the guidelines of the Committee on Safety of Medicines. 2. The data related to 20,695 consecutive acute general medical admissions on seven general medical wards (140 beds) and were collected over 3 years, from April 1990 to March 1993. 3. Over 3 years there were 1420 reports of suspected adverse drug reactions, a rate of 68.7 per 1000 admissions. 4. If the guidelines for reporting issued by the Committee on Safety of Medicines had been strictly followed, 477 yellow cards would have been sent (23.1 per 1000 admissions). In 357 of these reports (74.8%), the reaction had caused admission to hospital. Only 31 of the 477 potential cards (6.5%) involved black triangle drugs and 10 of these were for minor reactions. 5. Only 30 of the 477 potential yellow cards (6.3%) were known to have been sent. The majority of those reactions not reported were for drug-related admissions, most of which were for well-known reactions to established drugs. 6. We have confirmed and quantified the extent of under-reporting of serious suspected adverse drug reactions to the Committee on Safety of Medicines from our hospital medical unit.
first_indexed 2024-03-06T21:31:25Z
format Journal article
id oxford-uuid:44cc8f9c-e84a-43c4-8aca-00349caf8fb5
institution University of Oxford
language English
last_indexed 2024-03-06T21:31:25Z
publishDate 1996
record_format dspace
spelling oxford-uuid:44cc8f9c-e84a-43c4-8aca-00349caf8fb52022-03-26T15:03:53ZAdverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:44cc8f9c-e84a-43c4-8aca-00349caf8fb5EnglishSymplectic Elements at Oxford1996Smith, CBennett, PPearce, HHarrison, PReynolds, DAronson, JGrahame-Smith, D1. We have retrospectively analysed data collected by a local adverse drug reactions reporting scheme in an acute hospital medical setting and have determined the numbers and types of reactions that would have merited notification as yellow card reports according to the guidelines of the Committee on Safety of Medicines. 2. The data related to 20,695 consecutive acute general medical admissions on seven general medical wards (140 beds) and were collected over 3 years, from April 1990 to March 1993. 3. Over 3 years there were 1420 reports of suspected adverse drug reactions, a rate of 68.7 per 1000 admissions. 4. If the guidelines for reporting issued by the Committee on Safety of Medicines had been strictly followed, 477 yellow cards would have been sent (23.1 per 1000 admissions). In 357 of these reports (74.8%), the reaction had caused admission to hospital. Only 31 of the 477 potential cards (6.5%) involved black triangle drugs and 10 of these were for minor reactions. 5. Only 30 of the 477 potential yellow cards (6.3%) were known to have been sent. The majority of those reactions not reported were for drug-related admissions, most of which were for well-known reactions to established drugs. 6. We have confirmed and quantified the extent of under-reporting of serious suspected adverse drug reactions to the Committee on Safety of Medicines from our hospital medical unit.
spellingShingle Smith, C
Bennett, P
Pearce, H
Harrison, P
Reynolds, D
Aronson, J
Grahame-Smith, D
Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
title Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
title_full Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
title_fullStr Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
title_full_unstemmed Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
title_short Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
title_sort adverse drug reactions in a hospital general medical unit meriting notification to the committee on safety of medicines
work_keys_str_mv AT smithc adversedrugreactionsinahospitalgeneralmedicalunitmeritingnotificationtothecommitteeonsafetyofmedicines
AT bennettp adversedrugreactionsinahospitalgeneralmedicalunitmeritingnotificationtothecommitteeonsafetyofmedicines
AT pearceh adversedrugreactionsinahospitalgeneralmedicalunitmeritingnotificationtothecommitteeonsafetyofmedicines
AT harrisonp adversedrugreactionsinahospitalgeneralmedicalunitmeritingnotificationtothecommitteeonsafetyofmedicines
AT reynoldsd adversedrugreactionsinahospitalgeneralmedicalunitmeritingnotificationtothecommitteeonsafetyofmedicines
AT aronsonj adversedrugreactionsinahospitalgeneralmedicalunitmeritingnotificationtothecommitteeonsafetyofmedicines
AT grahamesmithd adversedrugreactionsinahospitalgeneralmedicalunitmeritingnotificationtothecommitteeonsafetyofmedicines